Your Top 10 most-cited badge
A badge for your website, a sentence for your CV, and a permanent page where anyone can check the rank.
The article
Amivantamab plus chemotherapy with and without lazertinib in EGFR-mutant advanced NSCLC after disease progression on osimertinib: primary results from the phase III MARIPOSA-2 study
Antonio Passaro, Jing Wang, Yan Wang, S.-H. Lee, Barbara L. Melosky, Jin‐Yuan Shih and 24 more
- Rank
- 6 of 3,639
- Percentile
- top 0.2%
- Where
- Annals of Oncology, 2023
- Citations
- 450
From the 2023 list, OpenAlex counts as of 2026-10-29.
Prefer not to be listed? The same link lets you withhold your name on every list; the article stays, your name does not. Questions: team@avidnote.com.